Copyright Reports & Markets. All rights reserved.

Global Malaria Prescription Medication Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Malaria Prescription Medication
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Malaria Prescription Medication Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Oral and Parenteral
    • 1.3.3 Intravenous
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Malaria Prescription Medication Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals
    • 1.4.3 Specialty Clinics
    • 1.4.4 Homecare
    • 1.4.5 Others
  • 1.5 Global Malaria Prescription Medication Market Size & Forecast
    • 1.5.1 Global Malaria Prescription Medication Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Malaria Prescription Medication Sales Quantity (2018-2029)
    • 1.5.3 Global Malaria Prescription Medication Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Zydus Healthcare
    • 2.1.1 Zydus Healthcare Details
    • 2.1.2 Zydus Healthcare Major Business
    • 2.1.3 Zydus Healthcare Malaria Prescription Medication Product and Services
    • 2.1.4 Zydus Healthcare Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Zydus Healthcare Recent Developments/Updates
  • 2.2 Sun Pharmaceutical Industries Ltd.
    • 2.2.1 Sun Pharmaceutical Industries Ltd. Details
    • 2.2.2 Sun Pharmaceutical Industries Ltd. Major Business
    • 2.2.3 Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Product and Services
    • 2.2.4 Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.3 Sanofi SA
    • 2.3.1 Sanofi SA Details
    • 2.3.2 Sanofi SA Major Business
    • 2.3.3 Sanofi SA Malaria Prescription Medication Product and Services
    • 2.3.4 Sanofi SA Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Sanofi SA Recent Developments/Updates
  • 2.4 GSK Plc.
    • 2.4.1 GSK Plc. Details
    • 2.4.2 GSK Plc. Major Business
    • 2.4.3 GSK Plc. Malaria Prescription Medication Product and Services
    • 2.4.4 GSK Plc. Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 GSK Plc. Recent Developments/Updates
  • 2.5 Novartis AG
    • 2.5.1 Novartis AG Details
    • 2.5.2 Novartis AG Major Business
    • 2.5.3 Novartis AG Malaria Prescription Medication Product and Services
    • 2.5.4 Novartis AG Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Novartis AG Recent Developments/Updates
  • 2.6 Cipla
    • 2.6.1 Cipla Details
    • 2.6.2 Cipla Major Business
    • 2.6.3 Cipla Malaria Prescription Medication Product and Services
    • 2.6.4 Cipla Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Cipla Recent Developments/Updates
  • 2.7 Viatris
    • 2.7.1 Viatris Details
    • 2.7.2 Viatris Major Business
    • 2.7.3 Viatris Malaria Prescription Medication Product and Services
    • 2.7.4 Viatris Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Viatris Recent Developments/Updates
  • 2.8 Lupin
    • 2.8.1 Lupin Details
    • 2.8.2 Lupin Major Business
    • 2.8.3 Lupin Malaria Prescription Medication Product and Services
    • 2.8.4 Lupin Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Lupin Recent Developments/Updates
  • 2.9 Advacare Pharma USA
    • 2.9.1 Advacare Pharma USA Details
    • 2.9.2 Advacare Pharma USA Major Business
    • 2.9.3 Advacare Pharma USA Malaria Prescription Medication Product and Services
    • 2.9.4 Advacare Pharma USA Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Advacare Pharma USA Recent Developments/Updates
  • 2.10 VLP Therapeutics
    • 2.10.1 VLP Therapeutics Details
    • 2.10.2 VLP Therapeutics Major Business
    • 2.10.3 VLP Therapeutics Malaria Prescription Medication Product and Services
    • 2.10.4 VLP Therapeutics Malaria Prescription Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 VLP Therapeutics Recent Developments/Updates

3 Competitive Environment: Malaria Prescription Medication by Manufacturer

  • 3.1 Global Malaria Prescription Medication Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Malaria Prescription Medication Revenue by Manufacturer (2018-2023)
  • 3.3 Global Malaria Prescription Medication Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Malaria Prescription Medication by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Malaria Prescription Medication Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Malaria Prescription Medication Manufacturer Market Share in 2022
  • 3.5 Malaria Prescription Medication Market: Overall Company Footprint Analysis
    • 3.5.1 Malaria Prescription Medication Market: Region Footprint
    • 3.5.2 Malaria Prescription Medication Market: Company Product Type Footprint
    • 3.5.3 Malaria Prescription Medication Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Malaria Prescription Medication Market Size by Region
    • 4.1.1 Global Malaria Prescription Medication Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Malaria Prescription Medication Consumption Value by Region (2018-2029)
    • 4.1.3 Global Malaria Prescription Medication Average Price by Region (2018-2029)
  • 4.2 North America Malaria Prescription Medication Consumption Value (2018-2029)
  • 4.3 Europe Malaria Prescription Medication Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Malaria Prescription Medication Consumption Value (2018-2029)
  • 4.5 South America Malaria Prescription Medication Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Malaria Prescription Medication Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Malaria Prescription Medication Sales Quantity by Type (2018-2029)
  • 5.2 Global Malaria Prescription Medication Consumption Value by Type (2018-2029)
  • 5.3 Global Malaria Prescription Medication Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Malaria Prescription Medication Sales Quantity by Application (2018-2029)
  • 6.2 Global Malaria Prescription Medication Consumption Value by Application (2018-2029)
  • 6.3 Global Malaria Prescription Medication Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Malaria Prescription Medication Sales Quantity by Type (2018-2029)
  • 7.2 North America Malaria Prescription Medication Sales Quantity by Application (2018-2029)
  • 7.3 North America Malaria Prescription Medication Market Size by Country
    • 7.3.1 North America Malaria Prescription Medication Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Malaria Prescription Medication Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Malaria Prescription Medication Sales Quantity by Type (2018-2029)
  • 8.2 Europe Malaria Prescription Medication Sales Quantity by Application (2018-2029)
  • 8.3 Europe Malaria Prescription Medication Market Size by Country
    • 8.3.1 Europe Malaria Prescription Medication Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Malaria Prescription Medication Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Malaria Prescription Medication Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Malaria Prescription Medication Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Malaria Prescription Medication Market Size by Region
    • 9.3.1 Asia-Pacific Malaria Prescription Medication Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Malaria Prescription Medication Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Malaria Prescription Medication Sales Quantity by Type (2018-2029)
  • 10.2 South America Malaria Prescription Medication Sales Quantity by Application (2018-2029)
  • 10.3 South America Malaria Prescription Medication Market Size by Country
    • 10.3.1 South America Malaria Prescription Medication Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Malaria Prescription Medication Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Malaria Prescription Medication Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Malaria Prescription Medication Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Malaria Prescription Medication Market Size by Country
    • 11.3.1 Middle East & Africa Malaria Prescription Medication Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Malaria Prescription Medication Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Malaria Prescription Medication Market Drivers
  • 12.2 Malaria Prescription Medication Market Restraints
  • 12.3 Malaria Prescription Medication Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Malaria Prescription Medication and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Malaria Prescription Medication
  • 13.3 Malaria Prescription Medication Production Process
  • 13.4 Malaria Prescription Medication Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Malaria Prescription Medication Typical Distributors
  • 14.3 Malaria Prescription Medication Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Malaria Prescription Medication market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Malaria Prescription Medication market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Malaria Prescription Medication market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Malaria Prescription Medication market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Malaria Prescription Medication market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Malaria Prescription Medication market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Malaria Prescription Medication
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Malaria Prescription Medication market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zydus Healthcare, Sun Pharmaceutical Industries Ltd., Sanofi SA, GSK Plc. and Novartis AG, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Malaria Prescription Medication market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Oral and Parenteral
    Intravenous
    Market segment by Application
    Hospitals
    Specialty Clinics
    Homecare
    Others
    Major players covered
    Zydus Healthcare
    Sun Pharmaceutical Industries Ltd.
    Sanofi SA
    GSK Plc.
    Novartis AG
    Cipla
    Viatris
    Lupin
    Advacare Pharma USA
    VLP Therapeutics
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Malaria Prescription Medication product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Malaria Prescription Medication, with price, sales, revenue and global market share of Malaria Prescription Medication from 2018 to 2023.
    Chapter 3, the Malaria Prescription Medication competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Malaria Prescription Medication breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Malaria Prescription Medication market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Malaria Prescription Medication.
    Chapter 14 and 15, to describe Malaria Prescription Medication sales channel, distributors, customers, research findings and conclusion.

    Buy now